SOTIO logo

SOTIO

SOTIO Biotech is shaping the future of cancer immunotherapies by translating compelling science into patient benefit. SOTIO’s robust clinical pipeline includes a differentiated superagonist of the attractive immuno-oncology target IL-15, a proprietary technology designed to improve on the efficacy of CAR T therapies and a new generation of potent and stable antibody-drug conjugates (ADCs). SOTIO is a member of the PPF Group.

Free account • No credit card • 5 profiles/day

Biotechnology Research 194 Employees Found Basel, Switzerland Founded 2010 10 Similar Companies
194 Employees Found
91% Email Coverage
$15.0M Est Revenue
4 Office HQ
10 Similar Companies
Jun '26 Last Verified

SOTIO – Company Information

Biotechnology Research
Founded 2010
51-200 employees View all
Českomoravská 2532/19b, Prague 9, Czech Republic, 190 00, CZ

Frequently asked questions about SOTIO

What is SOTIO email format?

The widely used SOTIO email format is {last} (e.g. smith@sotio.com) with 100% adoption across the company.

What is SOTIO customer service number?

To contact SOTIO customer service number in your country click here to find.

Who is the CEO of SOTIO?

Yong Z is the CEO of SOTIO.

Who are the decision makers in SOTIO?

The decision makers in SOTIO are Yong Z, Geoff Hodge, Pavel Solsky, etc. Click to Find SOTIO decision makers emails.